StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant (VRX) Derm NRx Up 2.2% Week-over-Week - RBC Capital
May 6, 2016 8:44 AM
RBC Capital analyst Douglas Miehm noted Valeant Pharmaceuticals (NYSE: VRX) Derm NRx increased 2.2% WoW, ophth NRx were up 2.7 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
FDA
Next Articles
Drop in Valeant (VRX) Share Price Hits Univ. of Texas' $24B Endowment
May 6, 2016 12:58 PM
Endo's (ENDP) Weak Results/Guidance Weigh on Specialty pharma (VRX) (HZNP) (MNK)
May 6, 2016 9:57 AM
Valeant Pharma (VRX) Forms New Patient Access and Pricing Committee; Will Oversee Drug Pricing
May 5, 2016 5:01 PM
Valeant Pharmaceuticals Announces Patient Access And Pricing Committee To Oversee Pricing Of Drugs
May 5, 2016 5:00 PM
Valeant's (VRX) Bausch + Lomb and IBM (IBM) Enter New Collaboration
May 5, 2016 8:06 AM
Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM
May 5, 2016 8:04 AM
